INTK .024

INTK is starting to show signs of a real nice reversal here! Look for vol. to increase into next week and continued bullish price action. We are betting big that INTK is gonna be another winner for us here in the near future!!

We will take a look at the weekly chart over the weekend.

Happy trading ;-)

BPAX!!! - Teva, BioSante Win FDA Approval to Sell Men’s Testosterone-Replacement Gel (news link here)

"BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante, of Lincolnshire, Illinois, licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized."

The price of BPAX hit a low of 0.68 (our original price alert on Jan. 22 here http://chartsbyoriginalnewt.blogspot.com/2012/01/bpax-068-short-term-play-on-chart-and.html )Tues. bouncing off the lower trend line of the 2 month channel, as investors were waiting on FDA decision and closed the regular trading hours at 0.76, after hours trading saw an increase in price of 0.35 on 4.66 mil shares traded.



BPAX support and resistance

Daily

60 min.

BPAX breakout! Possible 71% so far!! They just keep coming!!!

BPAX had an amazing day today on equally amazing volume. We have so far seen a possible 71% in gains since our original alert here http://chartsbyoriginalnewt.blogspot.com/2012/01/bpax-068-short-term-play-on-chart-and.html with a follow up here

http://chartsbyoriginalnewt.blogspot.com/2012/01/technical-update-on-bpax.html 

But this is not all we expect from BPAX in the short term. The chart is showing some resistance in the $1.12 - $1.26 area but we feel the momentum is enough (after hours saw a close of $1.11) and with the strong base of which we are moving off BPAX could see $1.50 (fib. 50% retrace) within the week. We do remind everyone to trade smart and take profits along the way ;-)

Keep in mind that the FDA date is approaching, only 1 week away, Feb. 14.

Co. website http://www.biosantepharma.com/index.php

"A subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is the licensee for Bio-T-Gel™ (testosterone gel) for the treatment of male hypogonadism or low testosterone levels. Bio-T-Gel™ was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel™ regulatory and marketing activities.

An NDA for Bio-T-Gel™ is pending with the FDA and has a PDUFA date of February 14, 2012. BioSante received $1.5 million upfront on signing the license agreement and will receive royalties upon commercialization. The current U.S. market for male testosterone products is over $1.2 billion"

60min. chart is a beauty! and notice the rising vol. through the day!!



Technical update on BPAX

BPAX is still looking good here in our books. We didn't have the quick move up like we were expecting from the earlier charts but BPAX is consolidating nicely here in the .60 - .70 range. (original post link  http://chartsbyoriginalnewt.blogspot.com/2012/01/bpax-068-short-term-play-on-chart-and.html )
The daily chart has been trading above the 20ma for just over 2 weeks now and today (Jan. 31) we had the Psar flip below price. Two more bullish signs to go along with our upcoming FDA date (Feb. 14) for BPAX's Bio-T gel. Which is starting to show a lot of positive sentiments toward approval in the chat rooms and analyst write ups!
 I want to send a congrats to those that were patient with DHT as well :-) Possible 74% gains so far! We will be sending out an update on ITKH soon also, as we try to keep on top of our winning streak! Financials should be coming out in a couple of weeks.
Happy trading and always trade responsibly ;-)

Daily

60 min.